Clincosm LogoSign in Get a demo

stage ii pancreatic cancer

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City

Recruiting
  • Metastatic Pancreatic Carcinoma
  • +6 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Oct 31, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester

Active, not recruiting
  • Colon Carcinoma Metastatic in the Liver
  • +13 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +3 more
  • Atlanta, Georgia
  • +3 more
Dec 15, 2021

Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 29, 2020

Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (gemcitabine HCl,

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +3 more
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 29, 2020

Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer Trial in Omaha (procedure, drug, other,

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • +8 more
  • 4-Dimensional Computed Tomography
  • +8 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 24, 2020

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • La Jolla, California
  • +13 more
Aug 30, 2018

Extrahepatic Bile Duct Cancer, Nausea, Vomiting Trial in Winston-Salem (drug, procedure, other)

Completed
Has Results
  • Extrahepatic Bile Duct Cancer
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 16, 2018

Adenocarcinoma of the Pancreas, Pancreatic Cancer, Recurrent Pancreatic Cancer Trial in Toronto (eribulin mesylate)

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +5 more
  • eribulin mesylate
  • Toronto, Ontario, Canada
    University Health Network-Princess Margaret Hospital
Sep 19, 2017

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage I Pancreatic Cancer Trial (bevacizumab, gemcitabine HCl,

Withdrawn
  • Adenocarcinoma of the Pancreas
  • +4 more
  • (no location specified)
Apr 27, 2015

Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer, Stage III Pancreatic Cancer Trial run by the NCI (Detox-B

Completed
  • Recurrent Colon Cancer
  • +13 more
  • Detox-B adjuvant
  • ras peptide cancer vaccine
  • Bethesda, Maryland
    Medicine Branch
Apr 27, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (cetuximab, gemcitabine

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +4 more
  • cetuximab
  • +3 more
  • Chicago, Illinois
    University of Chicago
Apr 28, 2014

Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Rochester (radiation therapy,

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • radiation therapy
  • +3 more
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Jul 15, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (sorafenib tosylate,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • gemcitabine hydrochloride
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jul 1, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (drug, biological,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • gemcitabine hydrochloride
  • +5 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 4, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in New York (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in New York (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas Trial in Philadelphia

Completed
  • Adenocarcinoma of the Colon
  • +41 more
  • recombinant fowlpox-CEA(6D)/TRICOM vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 24, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Houston

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Houston (temsirolimus,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 16, 2013

Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Fallopian Tube Cancer Trial in Philadelphia (EF5, motexafin

Terminated
  • Advanced Adult Primary Liver Cancer
  • +70 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jan 15, 2013

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,

Completed
  • Adult Anaplastic Astrocytoma
  • +85 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013